Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

New Cholesterol Meds May Lower Heart Risks, but Will They Break the Bank?
WSJ Pharmalot
Fri, 03/20/15 - 10:58 am
Tags:
PCSK9 inhibitors, Sanofi, Regeneron, Amgen
Is This a Megablockbuster Drug in the Making?
Investopedia
Wed, 03/18/15 - 08:16 am
Tags:
Amgen, Repatha, PCSK9 inhibitors
Amgen, Regeneron Stocks Go Up as Drugs Bring Cholesterol Down
Forbes
Tue, 03/17/15 - 08:47 am
Tags:
Amgen, Regeneron, PCSK9 inhibitors, alirocumab, evolocumab
Amgen: Looking for a Wild Card
Barron's
Tue, 03/17/15 - 08:11 am
Tags:
Amgen, PCSK9 inhibitors, Regeneron, AMG-145
3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week
24/7 Wall St
Mon, 03/16/15 - 09:13 am
Tags:
Amgen, evolocumab, Biogen Idec, BIIB037, OCA, obeticholic acid, Intercept Pharmaceuticals
New Cholesterol Drugs: Highly Effective But Important Questions Remain
Forbes
Mon, 03/16/15 - 09:08 am
Tags:
PCSK9 inhibitors, alirocumab, evolocumab, Amgen, Sanofi, Regeneron
Is The Biotechnology Bubble Turning Into Mania?
Forbes
Mon, 03/16/15 - 09:03 am
Tags:
biotech, Gilead Sciences, Amgen, Regeneron, Puma Biotechnology, Isis Pharmaceuticals, Pharmacyclics, Intercept Pharmaceuticals
Amgen scores a victory for PCSK9, halving cardio risks after one year
Fierce Biotech
Mon, 03/16/15 - 08:58 am
Tags:
Amgen, PCSK9 inhibitors, evolocumab
Could Amgen's Next Drug Be Worth $100 Billion?
Investopedia
Sat, 03/14/15 - 02:35 pm
Tags:
Amgen, evolocumab
Data on investigational cholesterol-lowering meds to be presented at cardiology meeting
Medical Marketing and Media
Thu, 03/12/15 - 10:14 pm
Tags:
PCSK9 inhibitors, Amgen, Repatha
The 4 Biggest Biotech Stocks In The Market
Yahoo/Benzinga
Thu, 03/12/15 - 07:55 am
Tags:
biotech, Celgene, Regeneron, Biogen Idec, Amgen, Gilead Sciences
Amgen: The biotech that's getting on the biosimilar R&D bandwagon
BioPharma Dive
Wed, 03/11/15 - 08:38 am
Tags:
Amgen, biosimilars, Zarxio, Neupogen
Onyx field reps spared in Amgen's 300-job bloodletting
Fierce Pharma Marketing
Wed, 03/11/15 - 08:20 am
Tags:
ONYX Pharmaceuticals, Amgen, M&A, layoffs, drug reps
Amgen to cut about 300 jobs, close one building in South San Francisco
Marketwatch
Tue, 03/10/15 - 07:02 pm
Tags:
Amgen, layoffs
Amgen, Inc. Plans For Biosimilar Launches
Bidness Etc.
Tue, 03/10/15 - 08:21 am
Tags:
Amgen, biosimilars, Roche, AbbVie, Neupogen
First Copycat Biotech Drug Spurs $250B Obamacare Savings
Forbes
Sat, 03/7/15 - 11:16 am
Tags:
Zarxio, Novartis, biologics, Amgen, Neupogen
The Top 10 Biotech Companies In The U.S.
Forbes
Fri, 03/6/15 - 11:43 am
Tags:
biotech, Gilead Sciences, Amgen, Celgene, Biogen Idec, Regeneron, Alexion, Vertex Pharmaceuticals, Illumina, Biomarin, Agilent
Novartis wins approval for first U.S. biosimilar drug
Yahoo/Reuters
Fri, 03/6/15 - 10:01 am
Tags:
Novartis, FDA, Neupogen, Zarxio, Sandoz, Amgen
Merck touts a bright future in biosimilars with a stable of would-be blockbusters
Fierce Biotech
Wed, 03/4/15 - 09:51 am
Tags:
Merck, biosimilars, AbbVie, Humira, JNJ, Remicade, Amgen, Enbrel, Samsung Bioepis, Biogen Idec
Was Onyx worth it? Amgen's case is looking up as Kyprolis bests Velcade in head-to-head trial
Fierce Pharma
Tue, 03/3/15 - 08:05 am
Tags:
ONYX Pharmaceuticals, Amgen, Velcade, Kyprolis, Multiple Myeloma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.